Alabama to update PSE tracking system
This article was originally published in The Tan Sheet
Executive SummaryThe Alabama state Senate March 9 passed a bill creating an electronic tracking system for sales of products with pseudoephedrine and ephedrine, precursors for methamphetamine. The bill, which awaits the governor's signature, modernizes paper logs that require retailers to record consumers' identifying information and purchases of PSE and ephedrine. The new system will notify retailers if a customer exceeds the sales limit for the drugs. Alabama is one of several states to require electronic tracking of PSE (1"The Tan Sheet" March 15, 2010, In Brief)
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2019.
Just over a year ago, AstraZeneca at last returned to growth and set about a reorganization that placed oncology at the heart of its plans for continued success. In Vivo talked to the executive vice-president of its Oncology Business Unit David Fredrickson about how the company hopes to become a major cancer player.